FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 122 filers reported holding FLEXION THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $219,000 | -97.5% | 27,832 | -93.5% | 0.00% | -96.7% |
| Q4 2019 | $8,882,000 | +29.6% | 429,101 | -14.2% | 0.09% | +16.5% |
| Q3 2019 | $6,853,000 | -33.7% | 500,065 | -40.5% | 0.08% | -24.0% |
| Q2 2019 | $10,340,000 | -39.2% | 840,650 | -38.3% | 0.10% | -42.9% |
| Q1 2019 | $17,003,000 | -37.2% | 1,362,386 | -43.0% | 0.18% | -52.5% |
| Q4 2018 | $27,054,000 | -45.7% | 2,389,960 | -10.2% | 0.38% | -24.6% |
| Q3 2018 | $49,804,000 | -44.2% | 2,661,900 | -22.9% | 0.51% | -47.1% |
| Q2 2018 | $89,197,000 | +7.6% | 3,450,547 | -6.7% | 0.96% | -6.4% |
| Q1 2018 | $82,900,000 | -11.7% | 3,699,242 | -1.3% | 1.03% | -18.6% |
| Q4 2017 | $93,889,000 | -2.0% | 3,749,572 | -5.4% | 1.26% | -6.4% |
| Q3 2017 | $95,793,000 | +11.0% | 3,961,647 | -7.2% | 1.35% | +5.6% |
| Q2 2017 | $86,282,000 | -25.2% | 4,267,164 | -0.4% | 1.28% | -34.4% |
| Q1 2017 | $115,294,000 | +38.4% | 4,284,412 | -2.2% | 1.94% | +18.3% |
| Q4 2016 | $83,289,000 | +6.9% | 4,379,002 | +9.9% | 1.64% | +22.7% |
| Q3 2016 | $77,888,000 | +20.8% | 3,986,098 | -7.5% | 1.34% | +4.5% |
| Q2 2016 | $64,467,000 | +107.3% | 4,307,870 | +27.4% | 1.28% | +109.7% |
| Q1 2016 | $31,098,000 | -21.9% | 3,380,245 | +63.5% | 0.61% | -4.5% |
| Q4 2015 | $39,831,000 | +18.0% | 2,067,001 | -9.0% | 0.64% | +19.6% |
| Q3 2015 | $33,762,000 | -32.9% | 2,272,009 | -1.1% | 0.54% | -18.9% |
| Q2 2015 | $50,285,000 | -2.6% | 2,297,150 | +0.2% | 0.66% | -7.9% |
| Q1 2015 | $51,626,000 | +62.5% | 2,292,467 | +45.7% | 0.72% | +51.6% |
| Q4 2014 | $31,776,000 | – | 1,573,848 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|